Hudock Inc’s Precigen PGEN Stock Holding History

Hudock Inc’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-11	Closed	–	–	683
2017 Q4	$0	Hold	11	–	–	﹤0.01%	666
2017 Q3	$0	Hold	11	–	–	﹤0.01%	665
2017 Q2	$0	Sell	11 -100	-90%	-$2.19K	﹤0.01%	621
2017 Q1	$2K	Buy	+111	New	+$2.48K	﹤0.01%	507

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Hudock Inc's PGEN Position: Q1 2018 in Review

Hudock Inc sold out of Precigen (PGEN) in Q1 2018, closing a stake of 11 shares.

Hudock Inc first reported a position in PGEN in Q1 2017 and held it in 4 quarters. The position peaked at $2K in Q1 2017. 166 funds tracked by Wall St. Rank hold PGEN as of Q1 2018.

Hudock Inc reported no remaining Precigen position as of Q1 2018 after selling out during the quarter.
Hudock Inc sold 11 Precigen shares in Q1 2018.
Hudock Inc first reported a position in Precigen in Q1 2017 and held it in 4 quarters.
Hudock Inc's Precigen position peaked at $2K in Q1 2017.
166 funds tracked by Wall St. Rank held Precigen as of Q1 2018.

Based on Hudock Inc's 13F filing for Q1 2018, filed 27 Apr 2018.